AHA EPI/Lifestyle and Cardiometabolic Health Scientific Sessions
ID Week: Invasive pneumococcal disease and seven-valent pneumococcal conjugate vaccine
SAN DIEGO – Sheldon L. Kaplan, MD discusses recent study results indicating that the 13-valent pneumococcal conjugate vaccine sharply reduced the incidence of disease associated with the new bacterial types. In addition, Kaplan discusses significant declines in overall incidence of invasive pneumococcal disease in children aged <2 years and in persons aged ≥65 years.
Safe, effective treatment is possible for children with S. aureus osteomyelitis
SAN DIEGO — Hospital admissions rates for children with venous thromboembolism related to community-acquired Staphylococcus aureus osteomyelitis appear to be increasing, but results of a study presented here during IDWeek 2012 indicated that these children can be treated with anticoagulants safely and effectively.